Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia
Go back to Telix’s TLX66 in Phase II Academic Study of Pediatric Leukemia| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.88 +0.15 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.73 | 52 Week High | $2.18 | |||
| Open | $11.87 | 52 Week Low | $0.30 | |||
| Day High | $11.98 | P/E | N/A | |||
| Day Low | $11.84 | EPS | $-3.32 | |||
| Volume | 43,113 | |||||
